Connect with us

Health

As Trump Targets Researchers, Europe Makes a Pitch to Attract Scientists

Published

on

As Trump Targets Researchers, Europe Makes a Pitch to Attract Scientists

As the Trump administration slashes support to research institutions and threatens to freeze federal funding to universities like Harvard and Columbia, European leaders are offering financial help to U.S.-based researchers and hoping to benefit from what they are calling a “gigantic miscalculation.”

“Nobody could imagine a few years ago that one of the great democracies of the world would eliminate research programs on the pretext that the word ‘diversity’ appeared in its program,” President Emmanuel Macron of France said on Monday.

He was speaking at the Sorbonne University in Paris during an event called Choose Europe for Science that was organized by the French government and the European Union.

It was unthinkable, Mr. Macron said, alluding also to the withdrawal of researchers’ visas in the United States, that a nation whose “economy depends so heavily on free science” would “commit such an error.”

Ursula von der Leyen, president of the European Commission, announced an investment of 500 million euros, or $566 million, at the conference to “make Europe a magnet for researchers” over the next two years.

Advertisement

Although that amount is not much compared to the billions in cuts American universities face, it comes on top of the $105 billion international research program called Horizon Europe that supports scientific breakthroughs, like genome sequencing and mRNA vaccines, Ms. Von der Leyen said.

She did not mention the United States by name, but she described a global environment where “fundamental, free and open research is questioned.”

“What a gigantic miscalculation!” she said.

In Europe, there is a widespread feeling that Mr. Trump has abandoned America’s traditional support for liberty, free speech and democracy through his embrace of autocrats and the assault on science and academia. That has created strains but also a sense of opportunity on the continent, where attracting the best scientific minds to vigorous and independent universities is seen as part of a broader campaign to “rearm” Europe as an independent power.

Over the longer term, the European Commission, the executive arm of the European Union, plans to double grants for researchers who relocate and to enshrine freedom of scientific research into a law called the European Research Area Act.

Advertisement

“The first priority is to ensure that science in Europe remains open and free. That is our calling card,” Ms. von der Leyen said.

The Trump administration’s attack on science and threats to universities were the main impetus for the conference, which was attended by government ministers and prominent researchers from across Europe. Increasingly, the United States is seen as a strategic adversary, and opening doors to American researchers and scientists is viewed as a long-term response to that challenge.

Mr. Macron’s message to scientists was this: “If you love freedom, come help us to remain free.”

France announced its own program to lure U.S.-based researchers last month. The government promised universities and research institutions in the country up to 50 percent of the funding needed to lure international researchers, including those working in areas under pressure from the Trump administration like climate studies and low carbon energy. But no particular funding was announced until Monday, when Mr. Macron said his government would commit $113 million to the program.

Alarms in Europe began sounding when the Trump administration slashed jobs and froze science grants at leading American institutions as part of cost-cutting measures. European dismay increased when the U.S. government attacked diversity programs and attempted to dictate to universities “whom they can admit and hire, and which areas of study and inquiry they can pursue,” in the words of Harvard’s president, Alan M. Garber.

Advertisement

Harvard has filed a lawsuit against the Trump administration over its $2.2 billion federal funding freeze. Mr. Trump mused last week about ending Harvard’s tax-exempt status.

The U.S. government has also fired staff at U.S. centers deemed to be at the pinnacle of scientific research, including at the National Oceanic and Atmospheric Administration, the National Science Foundation, the Centers for Disease Control and Prevention and the National Institutes of Health, the world’s largest funder of biomedical research.

At the same time, some federal agencies have removed words from websites and grant applications that were deemed unacceptable to the Trump administration. Among the terms considered taboo are “climate science,” “diversity” and “gender.”

Taken together, the actions have sent a chill through academia and research institutes, with scientists worried not just for their jobs but the long-term viability of their research.

“In the United States, once a paradise for researchers, academic freedom is being challenged. The line between truth and falsehood, between fact and belief, is being weakened,” Elisabeth Borne, France’s education minister, said Monday as she opened the conference.

Advertisement

Universities in France have been at the forefront of attempts to benefit from a potential American brain drain. Aix Marseille University is interviewing some 300 candidates for its Safe Place for Science program, which it launched in March in response to the Trump administration’s cuts. Since then, many other universities and institutions have followed suit.

“Our self-interest, as well as our values, now command us to be the refuge for knowledge wherever it is under pressure,” said Luis Vassy, the president of Sciences Po University in Paris.

François Hollande, a former French president, has proposed a law to create a “scientific refugee” status for researchers threatened for their work in their countries.

However, some university heads and professors have criticized the initiative. They argue that while France is attempting to draw American researchers, it has also been cutting higher education and research budgets to address the country’s ballooning budget deficit.

Advertisement

Health

Aging-related joint disorder increasingly affects people under 40, study finds

Published

on

Aging-related joint disorder increasingly affects people under 40, study finds

NEWYou can now listen to Fox News articles!

Cases of gout are rising in younger individuals, according to a global study.

The condition, which is a type of inflammatory arthritis, steadily increased in people aged 15 to 39 between 1990 and 2021, researchers in China announced.

Although rates vary widely between countries, the total number of young people with the condition is expected to continue rising through 2035.

WEIGHT LOSS DRUGS COULD ADD YEARS TO AMERICANS’ LIVES, RESEARCHERS PROJECT

Advertisement

The study, published in the journal Joint Bone Spine, investigated 2021 data from the Global Burden of Disease (GBD), spanning 204 countries within the 30-year timeframe.

The data measured gout prevalence, incidence and years lived with disability, tracking global trends over time. The results showed a global increase across all three outcomes.

Gout is expected to continue rising in young people through 2035. (iStock)

Prevalence and disability years increased by 66%, and incidence rose by 62%. In 2021, 15- to 39-year-olds accounted for nearly 14% of new gout cases globally, the study found.

Men from 35 to 39 years old and people in high-income regions had the highest burden, but high-income North America topped the list for highest rates.

Advertisement

‘SKINNY FAT’ WARNING ISSUED AS STUDY FINDS HIDDEN OBESITY BEHIND NORMAL BMI

Men were also found to have lived more years with gout due to high BMI, while women tended to have the condition as a link to kidney dysfunction, the study noted.

The total number of cases is expected to increase globally due to population growth, but the study projected that rates per population would decrease.

The researchers noted that data quality, especially in low-income settings, could have posed a limitation to the broad GBD data.

What is gout?

Gout is a common form of arthritis involving sudden and severe attacks of pain, swelling, redness and tenderness in the joints, according to Mayo Clinic. It most often occurs in the big toe.

Advertisement

CLICK HERE FOR MORE HEALTH STORIES

The condition occurs when urate crystals accumulate in the joint. These form when there are high levels of uric acid in the blood, which the body produces when it breaks down a natural substance called purines.

A gout flare-up can happen at any time, often at night, causing the affected joint to feel hot, swollen, tender and sensitive to the touch.

Urate crystals, described as sharp and needle-like, build up in the joint, causing intense pain and swelling. (iStock)

Purines can also be found in certain foods, like red meat or organ meats like liver and some seafood, including anchovies, sardines, mussels, scallops, trout and tuna, according to the Mayo Clinic. Alcoholic drinks, especially beer, and drinks sweetened with fruit sugar can also lead to higher uric acid levels.

Advertisement

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

Uric acid will typically dissolve in the blood and pass through the kidneys into urine, but when the body produces too much or too little uric acid, it can cause a build-up of urate crystals. These are described by the Mayo Clinic as sharp and needle-like, causing pain, inflammation and swelling in the joint or surrounding tissue.

Risk factors for gout include a diet rich in high-purine foods and being overweight, which causes the body to produce more uric acid and the kidneys to have trouble eliminating it.

Experts urge patients to seek medical attention for gout flare-ups. (iStock)

Certain conditions like untreated high blood pressure, diabetes, obesity, metabolic syndrome and heart and kidney diseases can increase the risk of gout, as well as certain medications.

Advertisement

A family history of gout can also increase risk. Men are more likely to develop the condition, as women tend to have lower uric acid levels, although symptoms generally develop after menopause.

CLICK HERE TO DOWNLOAD THE FOX NEWS APP

Untreated gout can cause worsening pain and joint damage, experts caution. It may also lead to more severe conditions, such as recurrent gout, advanced gout and kidney stones.

TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ

The Mayo Clinic advises patients to seek immediate medical care if a fever occurs or if a joint becomes hot and inflamed, which is a sign of infection. Certain anti-inflammatory medications can help treat gout flares and complications.

Advertisement

Fox News Digital reached out to the researchers for comment.

Continue Reading

Health

New study questions whether annual mammograms are necessary for most women

Published

on

New study questions whether annual mammograms are necessary for most women

NEWYou can now listen to Fox News articles!

A new study suggests that annual mammograms may not be the only effective approach for preventing breast cancer.

The research, published in the Journal of the American Medical Association (JAMA), tested a risk-based breast cancer screening approach against standard annual mammography.

The WISDOM randomized clinical trial, led by study authors from universities and healthcare systems across the U.S., considered more than 28,000 women aged 40 to 74 years old, splitting them into a risk-based screening group and an annual mammography group.

ERIN ANDREWS HAD ‘NO SYMPTOMS’ BEFORE CANCER DIAGNOSIS, PUSHES FOR EARLY SCREENINGS

Advertisement

Researchers calculated each woman’s individual risk based on genetics (sequencing of nine breast cancer genes) and other health factors. 

A new study suggests that annual mammograms may not be the only effective approach for preventing breast cancer. (iStock)

Those who were at the highest risk were advised to alternate between a mammogram and an MRI scan every six months. Patients with elevated risk were told to get an annual mammography and counseling.

Average-risk women were guided to get mammograms every two years, while low-risk individuals were advised to have no screening until they became higher risk or reached age 50.

HIDDEN TYPE OF BREAST CANCER COULD BE EXPOSED BY NEW BREAKTHROUGH TECH

Advertisement

The researchers found that risk-based screening did not lead to more advanced cancer diagnoses (stage 2B or higher) compared with annual screening, indicating that it is just as safe as traditional methods. The risk-based approach, however, did not reduce the number of biopsies overall, as researchers had hoped.

Among the risk-based group of women, those with higher risk had more screening, biopsies and detected cancers. Women at lower risk had fewer procedures.

The research, published in the Journal of the American Medical Association (JAMA), tested a risk-based breast cancer screening approach against standard annual mammography. (iStock)

“[The] findings suggest that risk-based breast cancer screening is a safe alternative to annual screening for women aged 40 to 74 years,” the researchers noted in the research summary. “Screening intensity matched individual risk, potentially reducing unnecessary imaging.”

CLICK HERE FOR MORE HEALTH STORIES

Advertisement

Fox News medical contributor Dr. Nicole Saphier, associate professor of radiology at Memorial Sloan Kettering Cancer Center in New Jersey, commented that while these findings are important, the study “completely sidelines” what screenings are designed to do — detect cancer early.

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

“If you don’t measure stage 0, stage 1 or stage 2A cancers, you can’t tell whether personalized screening delays diagnosis in a way that matters for survival and treatment intensity,” Saphier, who was not involved in the study, told Fox News Digital in an interview.

Those who were at the highest risk were advised to alternate between a mammogram and an MRI scan every six months. (iStock)

More than 60% of breast cancers in the U.S. are diagnosed at stage 1 or 2A, where cure rates exceed 90%, the doctor noted.

Advertisement

The trial doesn’t “fully evaluate” whether risk-based screening changes detection at the earliest and most treatable stages, where screening “delivers its greatest benefit,” according to Saphier.

CLICK HERE TO DOWNLOAD THE FOX NEWS APP

“Mammography is not without risk — radiation exposure, false positives, anxiety and potential over-diagnosis are real and should be acknowledged,” she said. “But it remains the most effective, evidence-based tool for detecting breast cancer early, when treatment is most successful.”

The expert added that labeling women under 50 as “low risk” is “outdated,” as breast cancer diagnoses are on the rise in younger females.

TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ

Advertisement

“Until long-term mortality data support alternative approaches, annual screening beginning at 40 for average risk women should continue,” Saphier added. “Women should be assessed for breast cancer risk by 25 years old to determine if screening should begin earlier.”

Continue Reading

Health

Detransitioner Chloe Cole shares complications after gender procedures: ‘I am grieving’

Published

on

Detransitioner Chloe Cole shares complications after gender procedures: ‘I am grieving’

NEWYou can now listen to Fox News articles!

Medical victim Chloe Cole was at the center of the U.S. Department of Health and Human Services’ Thursday announcement of proposed regulatory actions to end “sex-rejecting procedures” on minors.

The proposed regulatory actions by the HHS are part of President Donald Trump‘s January executive order calling on the department to protect children from “chemical and surgical mutilation.”

The department is rolling out a series of policy updates and regulatory actions that would effectively defund hospitals that provide gender transition procedures, according to an HHS official. 

NUMBER OF YOUNG ADULTS IDENTIFYING AS TRANSGENDER PLUNGES BY NEARLY HALF IN TWO YEARS

Advertisement

Cole, now 21 years old, went through the process of medical transition from female to male between the ages of 12 and 16.

The California native took to the stage alongside HHS Secretary Robert F. Kennedy Jr. and other officials Thursday to advocate for the protection of children. Afterward, she told Fox News Digital the puberty blockers, testosterone injections and double mastectomy she endured have irreversibly and permanently affected her health.

Detransitioner Chloe Cole joined HHS Secretary Robert F. Kennedy Jr. on Thursday as he announced proposed regulations ending gender treatments for children. (Fox News Digital)

“As soon as gender was in the picture, none of my doctors or psychologists asked the real questions that they should have,” said Cole. “The entire focus was on my feelings and what I wanted rather than what I really needed in that moment.”

What she needed, Cole said, was to be loved and affirmed for the way God created her — “as a young and yet tomboyish little girl.”

Advertisement

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

She maintained that her doctors neglected to share risks, only touting the “benefits” of stopping female puberty and using testosterone to promote body hair growth, musculature and different fat distribution.

“There was nothing they could say to me that would make me understand the gravity of what I was about to go through, because I was still growing up,” said Cole. “I had very little experience in the world, and I simply would not be mature enough to be equipped to undergo such a life-changing procedure in every way.”

“I had very little experience in the world, and I simply would not be mature enough to be equipped to undergo such a life-changing procedure in every way,” Cole, pictured above in both pictures, told Fox News Digital. (Chloe Cole; Fox News Digital)

Cole noted that her parents never thought she was transgender, but felt like the odds were stacked against them.

Advertisement

“At the time when we started going through this as a family, there really were no resources that would speak to the reality of transgenderism, especially for children,” she said. “Most people were not aware then that this was something that was even happening in our hospital systems.”

CLICK HERE FOR MORE HEALTH STORIES

Cole said her parents were warned that if they did not allow her to transition, she would likely commit suicide. 

“My legal guardians were forced to make this decision under duress,” she shared in a previous statement. “But even if my parents had supported transitioning medically from the start, no parent or any adult, ultimately, has a right to determine whether a child gets to be chemically sterilized or mutilated.”

“While there are only two sexes, there’s a million different ways that you can be yourself,” said Cole, pictured above during her surgeries.  (Chloe Cole)

Advertisement

Cole said she’s suffered numerous complications from her medications and surgery. “My quality of life is still being impacted to this day,” she wrote in her statement.

Her fertility status now remains unknown, she said. She will not be able to breastfeed because her breasts were surgically removed.

“As an adult, I am now grieving, and on top of that, the areolar skin grafts they used in my surgery began to fail two years afterward. I must wear bandages on my chest every day,” Cole wrote. 

“As an adult, I am now grieving.”

In 2023, Cole filed a lawsuit with the Center for American Liberty (CAL) against hospitals for pushing her into what she believes is medical mutilation.

Advertisement

Mark Trammell of CAL told Fox News Digital that Thursday’s HHS announcement “represents a critical acknowledgment that experimental medical interventions on children with gender distress have failed to meet basic standards of safety and effectiveness.”

Cole, who detransitioned after medical procedures, is warning others to wait and seek family support before transitioning. (Fox News Digital)

“It signals that medicine must return to its core ethical obligation: First, do no harm,” Trammell added. 

“We will continue fighting to ensure accountability for the institutions that promoted these practices and to secure justice for the children and detransitioners whose lives were forever altered.”

TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ

Advertisement

In a previous statement provided to Fox News Digital, Dr. Marc Siegel, Fox News senior medical analyst, said he is in favor of a “more conservative approach” for minors.

“Long-term effects of puberty blockers may include bone loss, trouble concentrating, interference with learning and interference with fertility,” he said. “I think it makes sense in most cases to treat underlying mental health concerns before jumping into treatments, including surgery, that may be difficult to reverse.”

“It makes sense in most cases to treat underlying mental health concerns before jumping into treatments.”

The doctor also emphasized that gender issues should not be overly politicized. “This means not superimposing an ideology or pushing physicians to act in a certain way or under pressure,” Siegel said. 

Cole began the gender transition process at age 12 and received a double mastectomy surgery at 15 years old. (Fox News Digital)

Advertisement

“The welfare of the child must come first. In this case, it means going very slowly and providing support to a child or teen with gender dysphoria.”

Cole shared that she hopes any children who are questioning whether they should transition wait. 

CLICK HERE TO DOWNLOAD THE FOX NEWS APP

While there are only two sexes, there are a million different ways that you can be yourself,” she added.

“God is there for you. He is the one who has created you this way, and you can seek his counsel,” Cole went on. 

Advertisement

“You can continue praying, and I think ultimately it’s connecting with your family, building your purpose in this world, and looking to the gospel and up to God.”

Fox News Digital’s Emma Colton contributed reporting.

Advertisement
Continue Reading

Trending